Stecyk Chrystyna Bedrij 4
4 · VACCINEX, INC. · Filed May 18, 2020
Insider Transaction Report
Form 4
VACCINEX, INC.VCNX
Stecyk Chrystyna Bedrij
Director
Transactions
- Award
Stock Option (Right to Buy)
2020-05-14+25,087→ 25,087 totalExercise: $3.95From: 2021-05-14→ Common Stock (25,087 underlying)
Footnotes (1)
- [F1]This option was granted pursuant to the Company's 2018 Omnibus Incentive Plan in a transaction exempt under Rule 16b-3 and expires on May 12, 2030 or five years following retirement or cessation of services, whichever occurs first.